Arginine vasopressin in scleroderma: Tissue expression, enhanced production by monocytes and modulation of collagen, endotheline-1, endothelial nitric oxide and prostacyclin Synthases expression levels
Epigenetic repression of the bone morphogenetic protein type II receptor expression in scleroderma endothelial cells: a possible basis for enhanced SSc endothelial vulnerability to apoptosis
